Literature DB >> 19034968

Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet.

Hideto Kawaratani1, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Mitsuteru Kitade, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui.   

Abstract

AIM: To investigate the innate immune reactivity of tumor necrosis factor-alpha (TNF-alpha), Toll-like receptor 4 (TLR4), and CD14 in the liver of non-alcoholic steatohepatitis (NASH) model rats.
METHODS: Male F344 rats were fed a choline-deficient L-amino-acid-defined (CDAA) diet. The rats were killed after 4 or 8 wk of the diet, and their livers were removed for immunohistochemical investigation and RNA extraction. The liver specimens were immunostained for TNF-alpha, TLR4, and CD14. The gene expressions of TNF-alpha, TLR4, and CD14 were determined by reverse-transcriptase polymerase chain reaction (RT-PCR). Kupffer cells were isolated from the liver by Percoll gradient centrifugation, and were then cultured to measure TNF-alpha production.
RESULTS: The serum and liver levels of TNF-alpha in the CDAA-fed rats increased significantly as compared with the control group, as did the immunohistochemical values and gene expressions of TNF-alpha, TLR4, and CD14 with the progression of steatohepatitis. TNF-alpha production from the isolated Kupffer cells of the CDAA-fed rats was elevated by lipopolysaccharide stimulation.
CONCLUSION: The expressions of TNF-alpha, TLR4, and CD14 increased in the NASH model, suggesting that TLR4 and CD14-mediated endotoxin liver damage may also occur in NASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034968      PMCID: PMC2773307          DOI: 10.3748/wjg.14.6655

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

2.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

3.  Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion.

Authors:  P O Seglen
Journal:  Exp Cell Res       Date:  1973-12       Impact factor: 3.905

4.  Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.

Authors:  A Haziot; E Ferrero; F Köntgen; N Hijiya; S Yamamoto; J Silver; C L Stewart; S M Goyert
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

5.  Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.

Authors:  J Crespo; A Cayón; P Fernández-Gil; M Hernández-Guerra; M Mayorga; A Domínguez-Díez; J C Fernández-Escalante; F Pons-Romero
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

6.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

Review 7.  Recent insights into the role of the innate immune system in the development of alcoholic liver disease.

Authors:  Laura E Nagy
Journal:  Exp Biol Med (Maywood)       Date:  2003-09

8.  The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats.

Authors:  J Hansen; D L Cherwitz; J I Allen
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  Prevention of fibrosis reduces enzyme-altered lesions in the rat liver.

Authors:  I Sakaida; M Kubota; K Kayano; K Takenaka; K Mori; K Okita
Journal:  Carcinogenesis       Date:  1994-10       Impact factor: 4.944

View more
  15 in total

1.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Masahito Uemura; Hiroshi Fukui
Journal:  Dig Dis Sci       Date:  2012-02-25       Impact factor: 3.199

3.  Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model.

Authors:  Rieko Shimozono; Kazumi Nishimura; Hideo Akiyama; Saeko Funamoto; Akiko Izawa; Takafumi Sai; Kana Kunita; Mie Kainoh; Tomohiko Suzuki; Norifumi Kawada
Journal:  J Interferon Cytokine Res       Date:  2015-02-25       Impact factor: 2.607

4.  Role of alcohol metabolism in non-alcoholic steatohepatitis.

Authors:  Susan S Baker; Robert D Baker; Wensheng Liu; Norma J Nowak; Lixin Zhu
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

5.  Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Hitoshi Yoshiji; Masao Fujimoto; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

Review 6.  Autoimmune features in metabolic liver disease: a single-center experience and review of the literature.

Authors:  Koichi Tsuneyama; Hayato Baba; Kentaro Kikuchi; Takeshi Nishida; Kazuhiro Nomoto; Shinichi Hayashi; Shigeharu Miwa; Takahiko Nakajima; Yuko Nakanishi; Shinji Masuda; Mitsuhiro Terada; Johji Imura; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 7.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530

Review 8.  The effect of inflammatory cytokines in alcoholic liver disease.

Authors:  Hideto Kawaratani; Tatsuhiro Tsujimoto; Akitoshi Douhara; Hiroaki Takaya; Kei Moriya; Tadashi Namisaki; Ryuichi Noguchi; Hitoshi Yoshiji; Masao Fujimoto; Hiroshi Fukui
Journal:  Mediators Inflamm       Date:  2013-12-09       Impact factor: 4.711

Review 9.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

Review 10.  Gut Microbiota and Host Reaction in Liver Diseases.

Authors:  Hiroshi Fukui
Journal:  Microorganisms       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.